Gamida Cell Ltd.
GMDADelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001600847
Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Gamida Cell Ltd. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 44 | 65 | +21 |
| Shares | 20.8M | 27.7M | +6.94M (+33.5%) |
| Value | $19.6M | $52.8M | +$33.2M (+169.4%) |
New holders (26)
Institutions that held Gamida Cell Ltd. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (5)
Institutions that held Gamida Cell Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Group One Trading, L.P. | 32,368 | $26.2K |
| Virtu Financial LLC | 32,545 | $26.0K |
| TD Waterhouse Canada Inc. | 4,000 | $3.24K |
| Quent Capital, LLC | 2,237 | $1.81K |
| Belpointe Asset Management LLC | 1,000 | $810 |